Autologous Hematopoietic Stem Cell Infusion for Myelosuppression after Bcma-CART Therapy in Relapsed Myeloma Patients

Abstract Background: The adoption of B cell mature antigen (BCMA) targeted chimeric antigen receptor (CAR) T cells is demonstrating promise prospects in refractory relapsed multiple myeloma (RRMM), however the persistent severe myelosuppression remains a serious complication. Autologous hematopoieti...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2019-11, Vol.134 (Supplement_1), p.1851-1851
Hauptverfasser:	Lin, Quande, Han, Lu, Zhou, Jian, Liu, Lina, Liu, Yuzhang, Yu, Fengkuan, Zhang, YangLi, Zuo, Wenli, Zhou, Keshu, Fang, Baijun, Gao, Quanli, Wei, Xudong, Liu, Delong, Song, Yongping
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!